Suchbegriffe: MITOGEN-ACTIVATED PROTEIN KINASE KINASES - GENETICS , . Treffer: 6
Berg, JL; Perfler, B; Hatzl, S; Uhl, B; Reinisch, A; Pregartner, G; Berghold, A; Penz, T; Schuster, M; Geissler, K; Prokesch, A; Müller-Tidow, C; Hoefler, G; Kashofer, K; Wölfler, A; Sill, H; Caraffini, V; Zebisch, A
EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity.
Leukemia. 2021; 35(5):1521-1526
Doi: 10.1038/s41375-021-01161-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Richtig, G; Richtig, E; Kashofer, K; Koch, L; Winter, G; Hoefler, G; Pichler, M; Ehall, B; Grübler, MR; Heinemann, A; Aigelsreiter, A
Testing and clinical implications for non-V600 BRAF mutations in metastatic NRASmt melanoma.
Br J Dermatol. 2017; 177(3):860-861
Doi: 10.1111/bjd.15222
Web of Science
PubMed
FullText
FullText_MUG
Hoffmann, K; Shibo, L; Xiao, Z; Longerich, T; Büchler, MW; Schemmer, P
Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma.
Anticancer Res. 2011; 31(11):3883-3890
Web of Science
PubMed
Becker, JC; Schrama, D; Bröcker, EB; Houben, R
Kinase inhibitors for the therapy of malignant melanoma
J Dtsch Dermatol Ges. 2005; 3(10):762-767
Doi: 10.1111/j.1610-0387.2005.05016.x
PubMed
FullText
FullText_MUG
Schramek, H; Feifel, E; Marschitz, I; Golochtchapova, N; Gstraunthaler, G; Montesano, R
Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells.
Am J Physiol Cell Physiol. 2003; 285(3): C652-C661.
Doi: 10.1152/ajpcell.00463.2002
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Marschitz, I; Lechner, J; Mosser, I; Dander, M; Montesano, R; Schramek, H
Differential expression of cell-cell adhesion proteins and cyclin D in MEK1-transdifferentiated MDCK cells.
Am J Physiol Cell Physiol. 2000; 279(5):C1472-C1482
Doi: 10.1152/ajpcell.2000.279.5.C1472
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG